Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA

Ann Rheum Dis. 2022 Mar;81(3):445-447. doi: 10.1136/annrheumdis-2021-221386. Epub 2021 Nov 24.

Klara Martinsson¹, Kerstin Dürholz^{2

3}, Georg Schett^{2

3}, Mario M Zaiss^{4

3}, Alf Kastbom¹

¹ Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
² Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
³ Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
⁴ Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany [email protected].

No abstract available

Keywords: arthritis; inflammation; rheumatoid; therapeutics.

Publication types